NewsBusiness Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves November 15, 2024 0 Facebook Twitter Pinterest WhatsApp ReddIt bodnarchuk/iStock via Getty Images Paulson & Co. exited its position in AngloGold Ashanti (NYSE:AU) in Q3, according to the fund’s latest 13F filing. The fund increased its stake in Madrigal Pharmaceuticals. Paulson & Co. also reduced its position in Altice USA (ATUS) in Related